We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Name | Symbol | Market | Type |
|---|---|---|---|
| Pfizer CDR CAD Hedged | NEO:PFE | NEO | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.04 | -0.32% | 12.37 | 12.30 | 12.48 | 12.41 | 12.23 | 12.38 | 79,903 | 21:55:00 |
From Jan 2020 to Jan 2025
Pfizer Inc. (PFE) said Thursday it completed its $68 billion acquisition of Wyeth (WYE) after having received final regulatory approvals on Wednesday.
Under the acquisition agreement, each outstanding share of Wyeth common stock has been converted into the right to receive $33 in cash without interest and 0.985 of a share of Pfizer common stock.
Wyeth shares will stop trading after the closing bell today. They were recently up 4 cents to $50.08. Pfizer shares were up 2 cents to $17.39
-By Wallace Witkowski, 415-439-6400; AskNewswires@dowjones.com
1 Year Pfizer CDR CAD Hedged Chart |
1 Month Pfizer CDR CAD Hedged Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
